Cochrane Abstracts
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis New Search for Studies and Content Updated (conclusions Changed)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed 14 August 2022.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed August 14, 2022.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis_New_search_for_studies_and_content_updated__conclusions_changed_
Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis New Search for Studies and Content Updated (conclusions Changed) [Internet]. In: Cochrane Abstracts. [cited 2022 August 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis_New_search_for_studies_and_content_updated__conclusions_changed_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
ID - 432156
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis_New_search_for_studies_and_content_updated__conclusions_changed_
DB - Evidence Central
DP - Unbound Medicine
ER -
